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  9 
Introduction 10 
Patients are suitably positioned to provide feedback on consultations with 11 
practitioners1. This feedback can help in identifying areas of performance that might not 12 
be identified by other methods2, 3.  13 
 14 
There is a lack of published research on patient feedback regarding consultations with 15 
pharmacists4. The Doctor Interpersonal Skills Questionnaire (DISQ) was identified as a 16 
questionnaire with good psychometric properties4. DISQ is owned by a private 17 
organisation called the ‘Client Focused Evaluations Program’ (CFEP), and has been 18 
converted into a generic questionnaire called the Interpersonal Skills Questionnaire 19 
(ISQ)5. The ISQ has been used in assessing CSs of different practitioners, including 20 
pharmacists, however no studies have been conducted and published in relation to its 21 
use with pharmacists. Therefore, this study aimed to use think aloud (TA) cognitive 22 
interviewing to explore the thinking process of patients as they completed the ISQ 23 
following a pharmacist’s consultation. The objectives of the study were to: (1) assess 24 
patients’ understanding of the ISQ items, (2) identify items of the ISQ that were 25 
interpreted differently from their main intentions, and (3) identify potential difficulties 26 
encountered while interpreting and answering the ISQ. 27 
 28 
Methods 29 
Research design 30 
A qualitative exploratory design that employed think aloud (TA) cognitive interviewing 31 
was used in this study. In TA, individuals are encouraged to vocalize their thoughts while 32 
completing a questionnaire6-8. The study received ethical approval by the National 33 
Health Service (NHS) Health Research Authority.  34 
 35 
Sample 36 
The population of interest were patients at a large teaching hospital in the East of 37 
England, UK, aged ≥ 18 years old, and who have just had a consultation with a 38 
pharmacist. Patients were excluded if they were unable to comprehend the English 39 
language (reading and/or writing), or if they were deemed not suitable to participate in 40 
the study as reported by their pharmacist. The study was conducted between October 41 
and December 2017. 42 
 43 
Potential participants were recruited from 2 clinics in the hospital: the orthopaedic and 44 
the cystic fibrosis outpatient clinics by convenience sampling. All potential participants 45 
received an invitation letter and an information sheet prior to attending the clinic. At 46 
the clinic, following a consultation with a pharmacist, those who agreed to participate in 47 
the study were directed to the researcher. 48 
 49 
Procedure 50 
Interviews were conducted by the researcher on a one to one basis with each 51 
participant in a private room and were audio recorded. Written consent was collected 52 
from each participant prior to starting.  53 
 54 
Data Collection 55 
Participants first practiced a warm up exercise to help them acclimatise to the process 56 
of TA and voicing their thoughts9. Further training was conducted where necessary until 57 
understanding of how to perform the TA process was expressed. Participants were then 58 
handed the ISQ (Appendix 1).  59 
 60 
The researcher sat facing away from the participant, in order to keep social contact with 61 
the participant to a minimum, and thus avoid interfering with his/her flow of thoughts. 62 
Participants were not interrupted while completing the questionnaire unless falling 63 
silent for 10-15 seconds, in which case they were reminded to ‘keep talking’. 64 
Retrospective probing was used at the end to gain more insights into participants’ 65 
thinking process. An example of used probing questions is shown in Table 1. Questions 66 
were used to accommodate the needs of each interview. 67 
 68 
Table 1  69 
Example of retrospective probing questions 70 
Probing questions 
What does the term ‘x’ mean to you? 
Was this question easy or hard to answer? 
I noticed that you have hesitated with question number ‘x’. Tell me what you were 
thinking. 
How did you arrive at that answer? 
What were you thinking about when you answered question ‘x’? 
Do you think it would be hard for other people to answer question ‘x’/questionnaire? 
How did you arrive at that answer? 
Can you repeat that question in your own words? 
 71 
Data Analysis 72 
Interview data were informally analysed (i.e. by writing notes while listening to 73 
recordings) since major difficulties encountered while completing a cognitive task could 74 
be identified by using an informal method of analysis8, 10 rather than using verbatim 75 
transcription and coding8. Revisions of the ISQ alongside with comparisons between the 76 
thinking strategies used by the different participants were made by the research team 77 
at the end of each TA round in order to decide whether comments given by participants 78 
reflected major problem(s) that necessitated making changes to the questionnaire. 79 
Subsequent TA rounds were continued until data saturation was achieved. 80 
 81 
Results 82 
Table 2 summarises the characteristics of all participants taking part in the study. Eight 83 
participants in total took part in the study (mean 48 years). Interviews lasted an average 84 
of 13 minutes.  85 
 86 
Table 2  87 
Characteristics of participants taking part in the TA study 88 
Participants No. (%) 
Gender 
- Female 
- Male 
 
4 (50%) 
4 (50%) 
Age 
- 18-24 years 
- 25-59 years 
- Over 60 years 
 
1 (12.5%) 
3 (37.5%) 
4 (50%) 
Clinic 
- Cystic fibrosis clinic 
- Orthopaedic 
 
3 (37.5%) 
5 (62.5%) 
First time to be counselled by this pharmacist 
- Yes 
- No 
 
5 (62.5%) 
3 (37.5%) 
 89 
Three rounds of TA interviews were conducted in this study; 4 participants in the first 90 
round, 2 in the second and third rounds. All participants showed understanding of the 91 
different items of the ISQ without reflecting major problems. Participants generally 92 
viewed the ISQ as a straight forward tool and easy to understand. No comments were 93 
given by participants that required immediate action, however, 2 questions in particular 94 
received similar comments by 2 participants (P4 from first round and P6 from second 95 
round), these comments are shown in Table 3.  96 
 97 
Table 3  98 
Participants’ comments to questions number 7 and 11 of the ISQ 99 
Question  Summary of comments 
Question 7: The 
opportunity the 
pharmacist gave 
me to express my 
concerns or fears 
was 
P4 and P6 shared the same comment of lacking fears/concerns to 
express to the pharmacist. However, P4 mentioned that the 
pharmacist did explain everything to him before he could show 
any concerns or fears; “I don’t have really any concerns, 
[pharmacist] understood all the …… the medication that I was 
taking and [pharmacist] explained to me anything that I needed 
to know before I could express any concerns or fears” (P4).  P4 
also questioned expressing concerns or fears to pharmacists as he 
prefers to go to the doctor instead. 
P6 indicated that this question does not apply to her since she 
doesn’t have any concerns/fears to convey to the pharmacist. 
However, P6 indicated that this question could be useful to other 
patients, especially those who have concerns/fears. 
Question 11: The 
pharmacist's 
concern for me 
as a person on 
this visit was 
This question was reread by P4, who also showed hesitation on 
answering it. P4 reasoned this to help him further understand it. 
However, P4 questioned the need for this question as in a 
hospital setting, people are working professionally and they show 
respect to their patients. 
P6 also showed hesitation with this question and referred to 
having only a professional relationship with the pharmacist. P6 
added that she did not meet with the pharmacist alone during the 
consultation, as the pharmacist was accompanied by a doctor at 
this visit, and that she was paying more attention to the doctor 
than to the pharmacist; “because the doctor came in with 
[pharmacist] as well, I noticed more what [doctor] was doing 
rather than what [pharmacist] was doing”. 
 100 
Meetings with research team were held at the end of each round to discuss its findings 101 
prior to the next round. Following round one, comments given by P4 were discussed, 102 
however, as P4 has answered all items of the questionnaire without expressing a clear 103 
problem, and a clear understanding was shown by him during the probing session, the 104 
team decided not to change the ISQ. Thus, the ISQ was not changed and the second 105 
round of cognitive interviewing was carried out. 106 
 107 
Participants in the second round also showed understanding of the questionnaire 108 
without reflecting major difficulties. Following this round, the researcher summarized 109 
findings of all TA interviews, including comments given by P4 and P6, a meeting was 110 
held with the research team for discussion. After listening to the audio recordings of P4 111 
and P6 interviews, and comparing the TA approach used by the other participants with 112 
respect to questions number 7 and 11, the team decided that there were no major 113 
problems indicated by all participants while answering the ISQ. 114 
 115 
The research team however did discuss the addition of an extra “not applicable” answer 116 
option to the whole questionnaire or just to question seven, or the addition of “skip this 117 
question if doesn’t apply” direction at the end of question seven. Nonetheless, the team 118 
found that this was not necessary since other participants provided good reasoning for 119 
their answers, and they did have some concerns which they discussed with the 120 
pharmacist. Additionally, P4 mentioned that the pharmacist did discuss everything 121 
before he could express any concerns/fears. Therefore, the questionnaire was decided 122 
to remain unchanged, and for interviews to be resumed until data saturation is reached. 123 
The third round was then conducted with 2 new participants. As the final participants 124 
did not reflect any problem with the ISQ, the team decided to terminate the process and 125 
keep the ISQ unchanged.  126 
 127 
Discussion 128 
This was the first study to use the TA cognitive interviewing in exploring the thinking 129 
process of patients while completing the ISQ following consultation with a pharmacist. 130 
The gathered evidence did not indicate a major problem with the ISQ. Most participants 131 
expressed that the ISQ is a straight forward questionnaire, easily understandable, and 132 
they do not expect other people to express any difficulty answering it with reference to 133 
pharmacy consultations. Thus, the findings of this study indicate that the ISQ could be a 134 
potentially useful questionnaire to be used in assessing and enhancing CSs of 135 
pharmacists. 136 
 137 
Two questions in particular; number 7 and 11 have received similar comments by 2 138 
participants. With respect to question seven, unlike other participants, the 2 139 
participants mentioned the lack of concerns/fears to express to the pharmacist. Patients 140 
generally vary in the way of expressing concerns to their medical condition to the 141 
practitioner. Three methods have been described in literature to be used including 142 
explicitly communicating concerns/fears to practitioners, using clues to indicate the 143 
presence of concerns for practitioners to explore, or choosing not to express these 144 
concerns and only communicating pertinent factual biomedical data11. Thus, it is a 145 
normal expectation for patients to have concerns, whether they choose to express it to 146 
the practitioner is their own choice. However, it remains the responsibility of the 147 
practitioner to make efforts to uncover the concerns/fears the patient has during the 148 
encounter, and it is equally important to identify whether the skills he/she used were 149 
helpful to allow the patient to comfortably express these concerns. 150 
 151 
As for question number 11, the same 2 participants viewed that it is a professional 152 
relationship under which pharmacists perform their duties when interacting with people 153 
without disrespecting them, and that their relationship with the pharmacist is 154 
professional. Issues raised by these participants could have been developed from the 155 
traditional image they may have for pharmacists. Across the years, pharmacy practice 156 
has gone through different stages of development and pharmacists have been awarded 157 
with various new roles that were not part of their working agenda in the past12. In spite 158 
of this, there is still a lack of understanding/recognition from patients to the expanding 159 
roles pharmacists are currently taking13, 14. Some patients do not wish to use 160 
pharmacists for these new roles15, and some do not accept these new roles to be 161 
undertaken by pharmacists16, 17. This was implicitly indicated by the comments given 162 
these 2 participants, indicating that a doctor would be a better option than a pharmacist 163 
to negotiate patient’s concerns/fears, or giving more attention to the doctor than the 164 
pharmacist. 165 
 166 
The research team discussed the addition of “not applicable” answer option to the 167 
whole questionnaire or the addition of “skip this question if it doesn’t apply” direction 168 
at the end of question seven, however, it was decided not to do so as this could 169 
generally encourage other respondents to misuse these options leading eventually to 170 
increasing missing data (item nonresponse) which may thus lead to reducing the 171 
efficiency of collected data, introducing bias when analysing it, and creating difficulties 172 
in data handling and analysis18, affecting thus the conclusions made from the sample 173 
undertaking the study and influencing the inferences made to the general population19. 174 
The team discussed that all of this could consequently create an obstacle against getting 175 
the full benefit of the ISQ and thus the team decided keep the questionnaire 176 
unchanged.  177 
 178 
Strengths and limitations 179 
To the best of our knowledge, this is the first study to use a TA interviews to examine 180 
the use of the ISQ in relation to hospital pharmacy consultations. Interviews were 181 
conducted at a hospital setting, a place where the questionnaire is intended to be used 182 
to collect patient feedback. Data for this study was derived from having participants 183 
being immersed in a real activity which could thus be more reliable than data collected 184 
from hypothetical situations. The study adds to the limited body of literature with 185 
respect to pharmacy consultation and patient feedback. 186 
 187 
However, some limitations have been encountered, one of which is the influence that 188 
the researcher’s presence may have had on participants while completing the ISQ which 189 
may have induced some participants to read questions even more thoroughly than what 190 
they would normally do if no one was around. 191 
 192 
With respect to sample size, although the used sample size was small and may not fully 193 
represent the population, some researchers indicated that around 80% of major 194 
problems could be identified with the first 4-5 participants when using the TA 195 
interviews, and with less new information to be identified with subsequent 196 
participants20, 21.  197 
 198 
Another limitation to the study was recruiting participants only from a single institution 199 
and from outpatient clinics. No inpatients were recruited for the study due to difficulties 200 
encountered with the logistics of conducting TA interviews with patients on the wards. 201 
It is not clear what impact inpatients might have regarding the ISQ especially that the 202 
way consultations are conducted on the wards is usually different from how they are 203 
conducted in clinics. 204 
 205 
Conclusions 206 
In this study, modification of the ISQ was unnecessary as conducted interviews 207 
demonstrated the lack of major problems with its use following a hospital pharmacist 208 
consultation. The ISQ is thus a potentially useful tool to be used for assessing pharmacy 209 
consultations. Future studies could take this tool forward to be tested with a larger 210 
sample size to evaluate the effectiveness and impact of patient feedback to developing 211 
CSs of pharmacy professionals. 212 
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